Advertisement

Iatrogenic Obesity

  • Scott Kahan
Chapter

Abstract

Factors outside diet and physical activity can contribute to weight gain. Most notably, many commonly used medications have a potential adverse effect of weight gain, which can lead to iatrogenic obesity – that is, obesity being caused, or contributed to, by medical treatment. Clinicians should become aware of medications with a high risk for weight gain and alternative medication options.

Keywords

Obesity Iatrogenic Weight gain Medication-induced weight gain Anti-obesity medication 

References

  1. 1.
    Petrin C, Kahan S, Turner M, et al. Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals. Obes Sci Pract. 2016;2(3):266–71.CrossRefGoogle Scholar
  2. 2.
    Apovian C, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.CrossRefGoogle Scholar
  3. 3.
    Domecq JP, Prutsky G, Leppin A, et al. Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:363–70.CrossRefGoogle Scholar
  4. 4.
    Bahr SM, Weidemann BJ, Castro AN, et al. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine. 2015;2:1725–34.CrossRefGoogle Scholar
  5. 5.
    Silverman BL, Martin W, Memisoglu A, et al. A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers. Schizophrenia Res. 2018;195:245–51.CrossRefGoogle Scholar
  6. 6.
    Hsieh A, Sweeting A, Suryawanshi A, Caterson ID. Drugs that cause weight gain and clinical alternatives to their use. In: Bray GA, Bouchard C, editors. Handbook of obesity. Boca Raton: CRC Press; 2014.Google Scholar
  7. 7.
    Paneni F, Luscher TF. Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. Am J Med. 2017;130(6):S18–29.CrossRefGoogle Scholar
  8. 8.
    Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259–72.CrossRefGoogle Scholar
  9. 9.
    Lord CC, et al. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. J Clin Invest. 2017;127(9):3402–6.CrossRefGoogle Scholar
  10. 10.
    Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial. JAMA Psychiat. 2017;74(7):719–28.CrossRefGoogle Scholar
  11. 11.
    Schwartz TL, Beale M. Psychotropic drug-induced weight gain alleviated with orlistat: a case series. Psychopharmacol Bull. 2003;37:5–9.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Scott Kahan
    • 1
  1. 1.Department of Health Policy, National Center for Weight and WellnessJohns Hopkins Bloomberg School of Public HealthWashingtonUSA

Personalised recommendations